Join
This site is intended for healthcare professionals
1
Managing Adverse Events in HR+/HER2– Advanced Breast Cancer
2
Management of EGFR-Mutated Metastatic NSCLC
3
Monitoring and Managing Hyperglycemia in Breast Cancer Therapy
4
A Paradigm Shift in Testing Strategies for HR+/HER2– aBC
5
Study Identifies How Antibodies Block Hantavirus Entry
Persistent Airway Hyperresponsiveness Signals Inflammation in Asthma
Blood Pressure Thresholds Reshape Nocturnal Hypertension Diagnosis
EMJ Dermatology 14.1 2026
EMJ Diabetes 14.1 2026
Lilly wins first China approval for oral weight loss drug
The CT-First Strategy in Chronic Coronary Syndromes
Higher Antibiotic Doses Fail to Boost H. pylori Eradication
Three WHO Announcements This Week That Matter for Health
Inhaled Steroids Linked to Worsened Sickle Cell Disease Markers
Weekly Injection Shows Promise for MASH and Liver Fibrosis
Closed-Loop Neurotech for Brain Stimulation: MedTech World Europe 2026
Adolescent Anaemia Emerges as Potential Cardiometabolic Risk Marker
CDC Travel Health Notices: Key Outbreak Alerts for Clinicians
Torque Teno Virus Signals Post-Transplant Cancer Risk
Plasma Tau Biomarkers Show Promise in Alzheimer’s Monitoring
Colorectal Cancer Screening Rates Vary Across Patient Groups
CT Radiomics Predicts Outcomes After Brainstem Haemorrhage
Salpingectomy Uptake Rises During Caesarean Delivery
Progressive Pulmonary Fibrosis After Nintedanib: Two-Year Outcomes
Systemic Sclerosis: Long-Term Outcomes After Stem-Cell Transplantation
Overactive Bladder Drugs Show No Dementia Risk Advantage
